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Background: The accumulation of thick stagnant mucus provides a suitable environment for the growth of
Pseudomonas aeruginosa and Staphylococcus aureus within the lung alveoli of cystic fibrosis (CF) patients. These
infections cause significant lung damage, leading to respiratory failure and death. In an artificial mucin containing
medium ASM+, P. aeruginosa forms structures that resemble typical biofilms but are not attached to any surface.
We refer to these structures as biofilm like structures (BLS). Using ASM+ in a static microtiter plate culture system,
we examined the roles of mucin, extracellular DNA, environmental oxygen (EO2), and quorum sensing (QS) in the
development of biofilm-like structures (BLS) by P. aeruginosa; and the effect of EO2 and P. aeruginosa on S. aureus
BLS.
Results: Under 20% EO2, P. aeruginosa strain PAO1 produced BLS that resemble typical biofilms but are confined to
the ASM+ and not attached to the surface. Levels of mucin and extracellular DNA within the ASM+ were optimized
to produce robust well developed BLS. At 10% EO2, PAO1 produced thicker, more developed BLS, while under 0%
EO2, BLS production was diminished. In contrast, the S. aureus strain AH133 produced well-developed BLS only
under 20% EO2. In PAO1, loss of the QS system genes rhlI and rhlR affected the formation of BLS in ASM+ in terms
of both structure and architecture. Whether co-inoculated into ASM+ with AH133, or added to established AH133
BLS, PAO1 eliminated AH133 within 48–56 h.
Conclusions: The thick, viscous ASM+, which contains mucin and extracellular DNA levels similar to those found in
the CF lung, supports the formation of biofilm-like structures similar to the aggregates described within CF airways.
Alterations in environmental conditions or in the QS genes of P. aeruginosa, as occurs naturally during the
progression of CF lung infection, affect the architecture and quantitative structural features of these BLS. Thus, ASM
+ provides an in vitro medium in which the effect of changing levels of substances produced by the host and the
bacteria can be analyzed to determine the effect on such structures and on the susceptibility of the bacteria within
the BLS to various treatments.Background
Cystic fibrosis (CF), an inherited disorder caused by
mutations in the gene that encodes the cystic fibrosis
transmembrane conductance regulator, affects approxi-
mately 30,000 Americans, primarily those of Northern
European origin [1,2]. These mutations cause a defi-
ciency in chloride secretion with ensuing accumulation
of thick, stagnant mucus within the lung alveoli of the
patients [1-4]. Nutrients in the thick mucus facilitate the* Correspondence: abdul.hamood@ttuhsc.edu
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reproduction in any medium, provided the orcolonization of various bacterial pathogens, including
Pseudomonas aeruginosa, Staphylococcus aureus, and
Haemophilus influenzae [3,5]. Colonization by these
pathogens elicits a strong host inflammatory response
which leads to destruction of the lung tissue and, ultim-
ately, death from respiratory failure [1,6,7]. P. aeruginosa
is one of the significant pathogens in chronic lung infec-
tions of CF patients [1,8].
Among the different factors that contribute to the
virulence of P. aeruginosa is its ability to form a biofilm,
a community within which bacteria are attached to a
substratum or to each other [9]. Within the biofilm, thetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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stance (EPS), which protects them from the effects of
the host immune system and from diverse antibiotics
[10-12]. Biofilm development occurs in stages that re-
quire specific bacterial factors at each stage. For ex-
ample, during the initial (attachment) stage of biofilm
formation, bacteria depend on both the flagellum-
mediated swimming motility and the pili-mediated
twitching motility [13]. A number of P. aeruginosa infec-
tions are associated with biofilm formation, including
chronic otitis media, heart valve endocarditis, and
chronic lung infections in CF patients [9,14].
Previously, studies have described synthetic mucin-
containing artificial sputum media (ASM) that mimics
the thick mucus within the lung of CF patients [15,16].
When grown in ASM, P. aeruginosa formed in tight
microcolonies suspended within the medium rather than
attached to the surface or free swimming as in standard
broth media [15,16]. Mucin is the main component of
secreted mucus, which also contains a large number of
plasma and non-plasma proteins, carbohydrates, amino
acids, nucleic acids, lipids, and electrolytes [17,18]. It has
been shown that mucin-P. aeruginosa interactions pro-
mote biofilm formation in the continuous culture flow-
through system [19].
In this study, we utilized a static microtiter plate cul-
ture system to investigate the effect of different condi-
tions on the development of P. aeruginosa biofilms in
mucus medium. Within the medium, P. aeruginosa
strain PAO1 formed structures that are biofilm-like,
but are not attached to the surface. The amount of
mucin and extracellular DNA in the medium, as well
as the level of environmental oxygen (EO2), are critical
for the development of these biofilm-like structures
(BLS). Additionally, one of the P. aeruginosa quorum
sensing systems, rhl, affects formation of the BLS. Further-
more, as it develops its BLS, P. aeruginosa eliminates
already established S. aureus BLS by a bactericidal
mechanism.
Results
Previous studies described a synthetic medium, ASM,
which closely mimics the sputum of CF patients [15,16].
When grown in ASM, PAO1 formed clusters, or microco-
lonies, that are attached to the components of the ASM
but not the abiotic surface [16]. In this study, we analyzed
the influence of different conditions on the formation of
these unique structures. We then examined the growth of
the P. aeruginosa strain PAO1/pMRP9-1 in the static
microtiter plate culture system using ASM+. First, we
eliminated the possibility that the addition of antibiotics
(either carbenicillin or erythromycin) to ASM+ to main-
tain the GFP plasmid had an adverse effect on either the
growth of the tested strains or BLS development by thesestrains (data not shown). Inoculated plates were incubated
at 37°C under 20% EO2. In situ CLSM of the gelatinous
masses at 48 h revealed the formation of structures com-
posed of numerous coalescing microcolonies that closely
resemble mature well-developed PAO1 biofilms
(Figure 1A, B). Quantitative analysis of the BLS using the
COMSTAT program [20], supported these findings: a total
biovolume of 6.52± 0.43 μm3/μm2 and a mean thickness
of 11.57± 0.28 μm was seen at 48 h (Table 1). Unlike the
development of PAO1 biofilms in other media, these
unique suspended biofilm-like structures (BLS) are
induced only within the gelatinous mass, as PAO1 did not
form any biofilm on the surface of the microtiter well
(Figure 1C). To further confirm these results, we grew
PAO1 as described above but inserted a small plastic
coverslip within the well of the microtiter plate. PAO1
again formed the unique BLS but failed to form any bio-
film on the plastic surface (data not shown). In contrast,
when we repeated the experiment with TSBDC, an iron-
deficient medium in which P. aeruginosa grows planktoni-
cally and develops conventional biofilm, PAO1 formed a
thick mature biofilm attached to the coverslip surface
(data not shown).
Extended incubation time enhances the formation of the
BLS
One condition that may influence the development of
the BLS in the ASM+ is length of incubation. Since the
growth of PAO1 in ASM+ appears similar to the macro-
colonies reported within the lungs of CF patients with
chronic P. aeruginosa infection [21], we inoculated
ASM+ with PAO1/pMRP9-1 as described above and
incubated the cultures in 20% EO2 at 37°C for up to 16 d.
From days 2 to 6, the BLS gradually developed to resem-
ble a complete, mature and well developed biofilm
(Figure 2A). Three-dimensional (3-D) images constructed
from the CLSM scans clearly show the gradual increase
in the size and the thickness of the BLS (Figure 2B).
Structural analysis revealed that between 2–3 and 2–
6 days, the BLS significantly increased in total biovolume
and mean thickness (Tables 1 and 2). In contrast, por-
tions of the BLS that are exposed to nutrients (the sur-
face to biovolume ratio) and roughness coefficient values
were significantly reduced (Tables 1 and 2). The total
surface area was significantly (P < 0.0001) decreased be-
tween 2–6 days only (Table 1). For the 16-d growth
experiments, we maintained the growth of the PAO1
BLS by adding fresh ASM+ to the media remaining in
the wells to maintain the original volume every 4 d to
replace volume lost to evaporation. At 16 d, PAO1 BLS
appears to be greater than at any time during the course
of the experiment (Figure 3). Due to enhanced growth
by the replacement of the medium, new microcolonies
appear to have developed atop the underlying thick
Figure 1 (See legend on next page.)
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Figure 1 P. aeruginosa PAO1 forms BLS within the ASM+. After 48 h of growth at 37°C under 20% EO2/static conditions, PAO1/pMRP9-1
developed BLS that were confined to the ASM+ and not attached to the surface of the microtiter plate. The composition of the ASM+ and the
bacterial inoculation are described in Methods. The gelatinous mass containing the BLS was visualized in situ by CLSM. (A) CLSM micrograph of
the PAO1/pMRP9-1 BLS; magnification, 10X; bar, 200.00 nm. (B) 3-D image analysis revealing the architecture of the BLS shown in (A); box, 800.00
pixels (px) W x 600 px H; bar, 100 px. (C) CLSM micrograph of the well bottom after the removal of the gelatinous mass showing no attached
bacteria or biofilm (the scattered fluorescence observed is due to autofluorescing debris).
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represent detached segments of the well developed bio-
film (Figure 3). Such detachment may occur mechanically
and would not represent the well known bacterial disper-
sion phenomenon. In bacterial dispersion, individual
planktonic cells and not biofilm segments are released
from the mature biofilm [14]. No biofilm attached to the
surface of the well of the microtiter plate at any time
point throughout the experiment (data not shown).
These results suggest that dynamic changes within occur
PAO1 BLS during growth in ASM+ over an extended
period of time.
Mucin and DNA concentrations influence the
development of the PAO1 BLS
Mucin, together with extracellular DNA, contributes to the







Time (under 20% EO2)
48 h 10 6.52 ± 0.43 11.6 ± 0.28
72 h 10 11.1 ± 0.40 15.5 ± 0.23
6 d 10 18.2 ± 0.32 17.8 ± 0.06
Mucin concentration (3 d under 20% EO2)
1X 10 11.1 ± 0.40 15.5 ± 0.23
0.5X 10 13.5 ± 0.24 17.0 ± 0.05
2X 10 15.4 ± 0.35 17.3 ± 0.08
DNA concentration (3 d under 20% EO2)
1X 10 11.1 ± 0.40 15.5 ± 0.23
0.5X 10 2.42 ± 0.54 4.37 ± 1.37
1.5X 10 2.48 ± 0.22 5.52 ± 0.64
Oxygen concentration (EO2)
g
20% 10 11.1 ± 0.40 15.5 ± 0.23
10% 10 19.4 ± 0.28 17.9 ± 0.04
0% 10 0.28 ± 0.19 0.41 ± 0.27
a Each experiment was done in duplicate. Two 10-image stacks were obtained from
were analyzed using the COMSTAT program [20]. Values represent the mean± SEM
bEstimates the biomass of the BLS.
cMeasures spatial size of the BLS.
dAssessment of the variation in the thickness of the BLS, or BLS heterogeneity.
eTotal of the area occupied in each image stack.
fEstimates the portion of the biofilm exposed to nutrients; biovolume divided by th
g20%, aerobic; 10%, microaerobic; 0%, anaerobic; cultures were grown for 3 d, excemain components of ASM+. To determine if variations in
the amount of mucin or DNA in ASM+ would affect the
formation of the BLS, we adjusted the concentration of
each component individually. With 0.5X mucin (2.5 mg/
ml) or 2X mucin (10 mg/ml), PAO1 formed BLS, but the
architecture was more diffuse in appearance than BLS seen
with 1X mucin (5 mg/ml) (Figure 4). In general, varying
the mucin concentration altered the structural parameters
of PAO1 BLS. Either reduced or elevated mucin concentra-
tions increased the biovolume and thickness significantly
while the roughness was significantly decreased in both
cases (Tables 1 and 2). Additionally, 0.5X mucin signifi-
cantly increased the total surface area, while 2X mucin
reduced the surface to biovolume ratio significantly
(Table 2). We eliminated the possibility that variations in
the amount of mucin simply affected the growth of PAO1




area × 107 (μm2)e
Surface to volume
ratio (μm2/μm3)f
0.53 ± 0.02 1.65 ± 0.24 1.54 ± 0.10
0.18 ± 0.02 2.15 ± 0.03 1.01 ± 0.04
0.02 ± 0.00 0.96 ± 0.12 0.28 ± 0.04
0.18 ± 0.02 2.15 ± 0.03 1.01 ± 0.04
0.08 ± 0.00 2.44 ± .045 0.94 ± 0.03
0.06 ± 0.00 1.97 ± .098 0.67 ± 0.05
0.18 ± 0.02 2.15 ± 0.03 1.01 ± 0.04
1.33 ± 0.20 0.76 ± .220 1.55 ± 0.15
1.07 ± 0.07 0.96 ± .086 2.02 ± 0.01
0.18 ± 0.02 2.15 ± 0.03 1.01 ± 0.04
0.01 ± 0.00 0.46 ± 0.12 0.13 ± 0.03
1.94 ± 0.04 0.07 ± 0.06 1.75 ± 0.30
random positions within the BLs. A total of 40-image stacks were analyzed
.
e surface area of the substratum.
pt 0% EO2 for 6d.
Figure 2 PAO1 BLS vary structurally over time. Bacterial inoculation and incubation for the development of BLS were done as described in
Figure 1, except incubation was continued for 6 d without changing the medium. (A) CLSM micrographs of BLS at 2, 3, and 6 d post-inoculation;
magnification, 10X; bars, 200.00 nm. (B) The 3-D architecture of the BLS shown in (A). Boxes, 800.00 px W x 600.00 px H; bars, 100 px.
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observed in each condition, approximately 5 X 109 CFU/
ml (Figure 4D).
Variation in the amount of DNA produced more dra-
matic differences. When the amount of DNA was







Time (under 20% EO2)
3d vs. 2d 10 Increasec 0.0002 Increase <0.0001
6d vs. 2d 10 Increase 0.0002 Increase 0.0002
Mucin concentration (3 d under 20% EO2)
2.0X vs. 1X 10 Increase 0.0002 Increase 0.0003
0.5X vs. 1X 10 Increase 0.0019 Increase 0.0007
DNA concentration (3 d under 20% EO2)
1.5X vs. 1X 10 Decrease <0.0001 Decrease <0.0001
0.5X vs. 1X 10 Decrease <0.0001 Decrease 0.0002
Oxygen concentration (EO2)
e
10% vs. 20% 10 Increase <0.0001 Increase <0.0001
0% vs. 20% 10 Decrease <0.0001 Decrease <0.0001
aAll strains carry pMRP9-1 and were grown without shaking.
bSee Table 1 for description of parameters.
cSignificant change with P value indicated below direction of change.
dNS, no significant difference.
e20%, aerobic; 10%, microaerobic; 0%, anaerobic; cultures were grown for 3 d, exceconfined to a small area of the gelatinous mass rather
than spread throughout the medium as observed with
1X DNA (Figure 5A, B). When we increased the amount
of DNA to 1.5X (6 mg/ml), individual cells were found
scattered throughout the gelatinous medium, but no




area × 107 (μm2)b
Surface to volume
ratio (μm2/μm3)b
Decrease <0.0001 NSd Decrease 0.0027
Decrease <0.0001 Decrease <0.0001 Decrease <0.0001
Decrease 0.0006 NS Decrease 0.0018
Decrease 0.0011 Increase 0.0290 NS
Increase <0.0001 Decrease <0.0001 Increase <0.0001
Increase 0.0013 Decrease 0.0008 Increase 0.0124
Decrease <0.0001 Decrease <0.0001 Decrease <0.0001
Increase <0.0001 Decrease 0.0287 Increase 0.0482
pt 0% EO2 for 6d.
Figure 3 Extending incubation to 16 d enhances the formation of PAO1 BLS. Bacterial inoculation and incubation for the development of
BLS were done as described in Figure 1, except fresh ASM+ was added to the wells at 4-d intervals to replace lost volume. (A) CLSM micrographs
of BLS at 16 d post-inoculation; magnification, 10X; bar, 200.00 nm. (B) The 3-D architecture of the BLS shown in (A). Boxes, 800.00 px W x 600.00
px H; bar, 100 px.
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BLS developed in the presence of either 0.5X or 1.5X
DNA were significantly less than those of BLS developed
in the presence of 1X DNA (Tables 1 and 2). In contrast,
the values of the roughness coefficient and surface to
biovolume ratio were significantly increased (Table 2).
This resembles the initial stage of biofilm development
on an abiotic surface in which P. aeruginosa colonizes
the surface and forms a single monolayer. As for the var-
iations in mucin, we enumerated the CFU/ml for PAO1
grown in ASM+ with 1X, 0.5X or 1.5X DNA, and again,comparable levels of growth were obtained in each con-
dition (Figure 5D).
The level of EO2 affects the formation of BLS
Previous studies suggested that within the lung alveoli of
CF patients, P. aeruginosa survives and grows under an
oxygen gradient of 10% EO2 to 0% EO2 [5,21,22]. The
experiments described above were conducted under 20%
EO2. Therefore, we compared the development of the
PAO1/pMRP9-1 BLS in ASM+ under 20%, 10% and 0%
EO2. Cultures were incubated for 3 d under 20% and
Figure 4 Changing the level of mucin within ASM+ influences the development of PAO1 BLS. Bacteria were inoculated in ASM+
containing 5 mg/ml (1X), 2.5 mg/ml (0.5X), or 10 mg/ml (2X) mucin and incubated for 3 d under 20% EO2/static conditions. The structures were
analyzed by CLSM and 3-D images were constructed. Architecture of PAO1 BLS formed in the presence of 1X (A), 0.5X (B), or 2X (C) mucin. Boxes,
800.00 px W x 600.00 px H; bars, 100 px. (D) After 3 d, the gelatinous mass was removed from each well and vortexed to suspend the bacteria.
The bacterial suspension was serially diluted and aliquots from each dilution were spotted on LB agar to determine the CFU/ml. Values represent
the means of at least three independent experiments ± SEM.
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mented with 10% potassium nitrate as a terminal elec-
tron acceptor [5] and incubated for 6 d. Under
anaerobic conditions, P. aeruginosa grows rapidly using
anaerobic respiration, which requires nitrate (NO3
−), ni-
trite (NO2
−), or nitrous oxide (N2O) as alternative ter-
minal electron acceptors [5]. As P. aeruginosa penetrate
the thick mucus within the lung alveoli of CF patients
and reach the hypoxic zone, they transit from aerobic to
anaerobic metabolism and begin to utilize the NO3
− and
or NO2
− present within the CF mucus [5]. Compared
with structures that formed under 20% EO2, those that
formed under 10% EO2 appeared more developed by
CLSM (Figure 6A), much more dense and reachingalmost twice the maximum depth (Figure 6B). Quantita-
tive structural analysis by COMSTAT confirmed that
compared with 20% EO2, the growth of PAO1 under
10% EO2 significantly increased the biovolume and mean
thickness of the BLS (Tables 1 and 2). However, the
values for the roughness coefficient, surface area, and
surface to biovolume ratio were significantly reduced
(Tables 1 and 2). In contrast, structures developed under
0% EO2 were smaller and limited to only a small portion
of the gelatinous mass within the well (Figure 6). These
structures were much less developed than BLS formed
under 20% EO2 as shown by the significantly reduced
mean thickness, total biovolume, and surface area
(Tables 1 and 2). However, the roughness coefficient and
Figure 5 Variations in the level of DNA within ASM+affect the development of PAO1 BLS. ASM+ containing 4 mg/ml (1X), 2 mg/ml (0.5X),
or 6 mg/ml (1.5X) unsheared salmon sperm DNA was inoculated with PAO1/pMRP9-1 and incubated for 3 d under 20% EO2/static conditions.
The structures were analyzed by CLSM and 3-D images were constructed. Architecture of PAO1 BLS formed in the presence of 1X (A), 0.5X (B), or
1.5X (C) DNA. Boxes, 800.00 px W x 600.00 px H; bars, 100 px. (D) After 3 d, the gelatinous mass was removed from each well and vortexed to
suspend the bacteria. The bacterial suspension was serially diluted and aliquots from each dilution were spotted on LB agar to determine the
CFU/ml. Values represent the means of at least three independent experiments ± SEM.
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(Tables 1 and 2). These results suggest that in ASM+,
maximum development of the PAO1 BLS occurs under
10% EO2, whereas the growth under 0% EO2 severe-
ly limits their development. Based on this finding,
we conducted the rest of the PAO1 BLS analysis under
10% EO2.
Different P. aeruginosa strains produce dissimilar BLS in
ASM+
As there are many strains of P. aeruginosa that differ
in their ability to produce conventional biofilm, we
compared the development of the BLS by PAK andPA103 under 10% EO2 with that of PAO1. These
strains were originally isolated from infected patients
and have been extensively utilized in in vitro and
in vivo virulence studies [10,23-26]. Additionally, we
examined the P. aeruginosa strain CI-4, a clinical iso-
late obtained from a patient with a chronic lower re-
spiratory infection (30 days with the same strain) [27].
These strains were transformed with pMRP9-1 (for
GFP expression) and grown in ASM+ for 3 d and the
BLS analyzed as described in Methods. None of the
PAK BLS parameters were significantly different from
those of PAO1 BLS (Tables 3 and 4; Figure 7). With
respect to PA103 BLS, only the total biovolume and
Figure 6 The level of EO2 influences the development of PAO1 BLS in ASM+. Cells were inoculated into ASM+ and the cultures were
incubated for 3 d under 20% or 10% EO2. To obtain growth of PAO1 anaerobically, 10% potassium nitrate was added as a terminal electron
acceptor and incubation continued for 6 d in 0% EO2. The biofilms were analyzed as described in Figure 3. (A) CLSM micrographs of the BLS;
magnification, 10X; bar, 200.00 nm. (B) The 3-D architecture of the BLS shown in (A); boxes, 800.00 px W x 600 px H; maximum depth, 20% EO2
88.00 μm, 10% EO2 217.00 μm, 0% EO2 56.00 μm; bar, 100 px.
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son with PAO1 BLS (Table 3 and 4; Figure 7). In con-
trast, CI-4 produced BLS that were significantly lowerFigure 7 P. aeruginosa strains vary in their ability to develop BLS in A
transformed with pMRP9-1. The strains, plus PAO1/pMRP9-1, were grown in
analyzed as described in Figure 3. (A) CLSM micrographs of the BLS; magn
shown in (A); boxes, 800.00 px W x 600 px H; bars, 100 px.than those of PAO1 BLS in total biovolume, mean
thickness, and total surface area but significantly
higher than PAO1 in roughness coefficient and surfaceSM+. P. aeruginosa strains PAK, PA103, and CI-4 (a clinical isolate) were
ASM+ under 10% EO2 without shaking for 3 d. The BLS were
ification, 10X; bar, 200.00 nm. (B) The 3-D architecture of the BLS










area × 107 (μm2)b
Surface to volume
ratio (μm2/μm3)b
Prototrophs and clinical isolate
PAO1 10 18.2 ± 0.69 17.5 ± 0.12 0.05 ± 0.01 0.73 ± 0.23 0.28 ± 0.07
PAK 10 13.7 ± 2.82 13.2 ± 2.62 0.05 ± 0.02 0.62 ± 0.05 0.27 ± 0.06
PA103 10 10.7 ± 0.08 12.6 ± 2.13 0.07 ± 0.03 1.32 ± 0.50 0.61 ± 0.21
CI-4 10 0.48 ± 0.17 0.77 ± 0.45 1.67 ± 0.12 0.23 ± 0.84 2.45 ± 0.02
Quorum-sensing mutants
PAO1 (wt) 10 18.2 ± 0.69 17.5 ± 0.12 0.05 ± 0.01 0.73 ± 0.23 0.21 ± 0.07
PAO-R1 (ΔlasR) 10 19.3 ± 0.43 18.0 ± 0.00 0.02 ± 0.00 0.43 ± 0.15 0.12 ± 0.04
PAO-JP1(ΔlasI) 10 17.6 ± 1.45 17.8 ± 0.15 0.02 ± 0.02 0.65 ± 0.26 0.22 ± 0.11
PDO111 (ΔrhlR) 10 7.29 ± 0.10 8.26 ± 0.05 0.13 ± 0.01 1.10 ± 0.08 0.79 ± 0.04
PDO100 (ΔrhlI) 10 6.61 ± 2.25 8.65 ± 2.49 0.67 ± 0.12 0.98 ± 0.14 1.01 ± 0.23
PW2798c (ΔpqsA) 10 18.4 ± 0.30 17.7 ± 0.08 0.03 ± 0.01 0.70 ± 0.10 0.20 ± 0.03
aAll strains carry pMRP9-1 and were grown for 3 d under 10% EO2 without shaking.
bSee Table 1 for description of parameters.
cPW2798::pqsA-lac.
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formed BLS throughout the gelatinous mass (Tables 3
and 4; Figure 7). These results indicate that P. aerugi-
nosa strains differ in their ability to produce BLS
within the ASM+.
Quorum sensing affects the development of PAO1 BLS
in ASM+
The three quorum sensing (QS) systems las, rhl, and pqs
contribute to the development of P. aeruginosa biofilms







Prototrophs and clinical isolate
PAK vs. PAO1 10 NSc NS
PA103 vs. PAO1 10 Decreased 0.0004 Decrease 0.031
CI-4 vs. PAO1 10 Decrease <0.0001 Decrease <0.00
Quorum-sensing mutants
PAO-R1 vs. PAO1 10 NS Increase 0.024
PAO-JP1 vs. PAO1 10 NS NS
PDO111 vs. PAO1 10 Decrease <0.0001 Decrease <0.00
PDO100 vs. PAO1 10 Decrease 0.0026 Decrease 0.012
PW2798 vs. PAO1 10 NS NS
aAll strains carry pMRP9-1 and were grown under 10% EO2 without shaking.
bSee Table 1 for description of parameters.
cNS, no significant difference.
dSignificant change with P value indicated below direction of change.failed to form well developed biofilms compared with the
PAO1 parent strain [28-30]. Using a conventional biofilm
medium (LB broth), we compared the biofilm developed
on a plastic cover slip in a microtiter plate well by PAO1
and its lasR, lasI, rhlR, rhlI, and pqsA mutants. With the
exception of the medium, the biofilms were developed
under the same conditions that we used to develop the
BLS. Compared with PAO1, all QS mutants produced
reduced biofilms (data not shown). We then examined the
contribution of the QS systems to the formation of the








3 NS NS NS
01 Increase <0.0001 Decrease 0.0417 Increase <0.0001
1 Decrease 0.0172 NS NS
NS NS NS
01 Increase 0.0027 NS Increase <0.0001
0 Increase 0.0020 NS Increase 0.0175
NS NS NS
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The mutants were transformed with pMRP9-1 and the de-
velopment of the BLS by the transformants was examined
under 10% EO2 for 3 d at 37°C.
The las mutants PAO-R1 (ΔlasR) and PAO-JP1 (ΔlasI)
produced BLS that visually and architecturally resembled
each other (Figure 8A, B). With respect to the five tested
parameters, BLS produced by PAO-JP1 were not signifi-
cantly different from those BLS produced by PAO1
(Tables 3 and 4). The mean thickness of BLS produced by
PAO-R1 was significantly higher than that of PAO1 BLS
while the roughness coefficient was significantly lower
(Tables 3 and 4). The pqs mutant PW728::pqsA-lacZ pro-
duced BLS that were not significantly different from PAO1
BLS (Figure 8; Tables 3 and 4). The biovolume and mean
thickness of BLS produced by either the rhlI mutant
(PDO100) or rhlR (PDO111) were significantly less than
those produced by PAO1 (Figure 8; Tables 3 and 4). In
contrast the values of the roughness coefficient and the
surface to biovolume ratio were significantly higher than
those for PAO1 BLS (Figure 8; Table 3 and 4). These
results suggest that among all three QS systems, rhlI and
rhlR have a major impact on the development of BLS in
ASM+ by PAO1.
S. aureus develops BLS under 20% EO2 but not 10% EO2
S. aureus is one of the first microorganisms that colonize
and grow within the thick mucus in the lung alveoli of
CF patients [8]. Thus, we determined whether S. aureus
would develop BLS in ASM+ under 20% or 10% EO2.
The S. aureus strain AH133 which carries the GFP plas-
mid pCM11, was grown for 3 d at 37°C. Under 20%
EO2, AH133 produced a well developed BLS within the
entire gelatinous mass (Figure 9). However, under 10%
EO2, the structures were far less developed with individ-
ual cells/small microcolonies scattered within the gelat-
inous mass (Figure 9). Compared to BLS produced
under 20% EO2, total biovolume, mean thickness, and
surface area of BLS produced under 10% EO2 were sig-
nificantly reduced (P < 0.0001 for each value) (Table 5).
In contrast, the roughness coefficient and surface to bio-
volume ratio values were significantly increased
(P < 0.0001 for each value) (Table 5). This suggests that
unlike P. aeruginosa, S. aureus produces more developed
BLS under 20% EO2 rather than under 10% EO2.
P. aeruginosa eliminates BLS established by S. aureus
within ASM+
The lungs of CF patients are colonized with a variety of
pathogens, including S. aureus, P. aeruginosa, and K.
pneumoniae, over the course of time [1]. However, as
the disease progresses, the predominate pathogen within
the CF infected lung is P. aeruginosa [1,8]. Previous
studies showed that QS-controlled extracellular factorsproduced by P. aeruginosa, including quinoline mole-
cules and LasA, inhibited the planktonic growth of
S. aureus and S. epidermidis [31,32]. Additionally, recent
studies showed that the P. aeruginosa extracellular poly-
saccharide as well as the organic compound cis-2-decenoic
acid disrupted established biofilms produced by
Gram-positive bacteria [33]. Therefore, we first deter-
mined if PAO1 inhibits the growth of the S. aureus
strain AH133 in ASM+. We co-inoculated ASM+ with
approximately 1 x 107 CFU/ml each of PAO1 and
AH133 and incubated the culture for 48 h at 37°C
under 20% EO2. After 48 h, about 1 x 10
9 CFU/ml of
PAO1 was recovered from the gelatinous ASM+ mass,
but no CFU of AH133 (Figure 10A). We obtained
similar results when we repeated the experiments
using TSBDC, a growth medium that supports plank-
tonic growth of both organisms (Figure 10B). These
results suggest that similar to other previous observa-
tions, P. aeruginosa eliminates S. aureus, when the
two are grown together at the same time.
To simulate the scenario in which S. aureus colonizes
the CF lung first and P. aeruginosa follows, we then
examined the effect of PAO1 on partially developed
(8 h) AH133 BLS. As AH133 expresses GFP, we trans-
formed PAO1 with pMP7605, a plasmid from which
RFP is expressed constitutively [34], to allow
visualization of each strain within the BLS. Individually,
the strains produced well developed BLS in ASM+
(Figures 2, 10A). At 8 h post inoculation, AH133 formed
a defined structure (Figure 11A). We then added PAO1/
pMP7605 (at a starting density similar to that used to
initiate the AH133 culture) and continued incubation
for 56 h. The cultures were analyzed at 8- and 16-h
intervals to 64 h for the AH133 alone and 56 h post
addition of PAO1/pMP7605 for changes in the BLS pro-
duced by AH133 and the development of any PAO1 BLS
(Figure 11A, B). At 16 and 24 h post-initiation, AH133
produced well-developed mature BLS (Figure 11A). The
AH133 BLS changed in appearance over the rest of the
time course, but did not disappear (Figure 11A). In con-
trast, in the dual culture, the AH133 structure was con-
siderably reduced at the corresponding time points
(Figure 11B). By 32 h only remnants of the AH133 BLS
remained, and by 40–56 h, the AH133 BLS appeared to
be completely replaced by well-developed PAO1 BLS
(Figure 11B). The regression of AH133 structure appears
to be due to the expansion of the PAO1 structure at 8,
16, and 32 h post-initiation (Figure 11B).
This observed phenomenon could be due to the dis-
persion of the AH133 BLS or a bactericidal effect of
PAO1 on AH133. Therefore, at each time point, the gel-
atinous masses containing AH133 alone or AH133 plus
PAO1 were vortexed, serially diluted, and the CFU/ml
determined. Aliquots of each dilution were spotted on
Figure 8 Loss of individual QS genes affects BLS formation. PAO1 strains defective in the lasR (PAO-R1), lasI (PAO-JP1), rhlR (PDO111), rhlI
(PDO100), or pqsA (PW2798::pqsA-lacZ) genes were transformed with pMRP9-1 and the transformants plus PAO1/pMRP9-1 as a control were
grown in ASM+ under 10% EO2 without shaking for 3 d. The BLS were analyzed as described in Figure 3. (A and C) Representative micrographs
of the BLS; magnification, 10X; bar, 200.00 nm. (B and D) Respective 3-D images constructed from the CLSM micrographs. Boxes, 800.00 px W x
600 px H; bars, 100 px.
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nitol salt agar for S. aureus. At all tested time points, the
CFU/ml of the single AH133 biofilm was similar (about1 x 107) (Figure 11C, white bars). However, the CFU/ml
of AH133 within the mixed BLS was visibly reduced 8 h
after addition of PAO1 and significantly reduced at 40
Figure 9 Growth under 10% EO2 reduces S. aureus AH133 BLS development. S. aureus strain AH133 was grown in ASM+ under 20% EO2 or
10% EO2 without shaking for 3 d. The BLS were analyzed as described in Figure 3. (A) Representative micrographs of the BLS; magnification, 10X;
bar, 200.00 nm. (B) Respective 3-D images constructed from the CLSM micrographs. Boxes, 800.00 px W x 600 px H; bars, 100 px.
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addition of PAO1 (Figure 11C, green bars). In contrast,
the CFU/ml of PAO1/pMP7605 within the mixed BLS
dropped between 8 and 16 h post biofilm initiation but
did not change significantly after 16 h (Figure 11C, red
bars). These results suggest that PAO1 exerts a bacteri-
cidal effect, and that the development of the P. aeruginosa
BLS in the co-culture proceeded at the expense of the







20% 9 7.00 ± 0.46 7.57 ± 0.50
10% 9 0.22 ± 0.03 0.27 ± 0.04
aStrains were grown for 3 d without shaking.
bSee Table 1 for description of parameters.Discussion
CF sputum is a highly viscous secretion in which PAO1
grows readily. PAO1 forms conventional biofilms on abi-
otic surfaces [13,19,35], but it develops macrocolonies,
tight aggregates consisting of numerous microcolonies,
in ASM and the CF lung [16,21]. While PAO1 formed a
typical flat undifferentiated biofilm that completely cov-
ered the substratum with a homogenous distribution of




area × 107 (μm2)b
Surface to volume
ratio(μm2/μm3)b
0.58 ± 0.17 0.76 ± 0.12 0.57 ± 0.09
1.90 ± 0.02 0.07 ± 0.00 1.59 ± 0.01
Figure 10 PAO1 inhibits AH133 in co-culture. Overnight LB cultures of AH133 and PAO1/pMRP9-1 were pelleted, washed, and resuspended in
PBS. Resuspended cells of each species were inoculated into ASM+ (A) or TSBDC (B) at an initial OD600 of approximately 0.015. The CFU/ml of
each species was determined at the time of inoculation (0-time) and after 48 h of growth using selective media (Methods). The graphs show
CFU/ml obtained from BLS in ASM+ (A) and planktonic growth in TSBDC (B). Values represent the means of at least three independent
experiments ± SEM.
Haley et al. BMC Microbiology 2012, 12:181 Page 14 of 20
http://www.biomedcentral.com/1471-2180/12/181grew almost exclusively as discrete microcolonies that
eventually formed a mature biofilm on a mucin-covered
glass surface [19]. Based on these results, Landry et al.
suggested that mucin interacts with specific PAO1 adhe-
sins thereby immobilizing the bacteria onto the glass
surface [19]. In our analysis, the observed BLS developed
exclusively within the gelatinous mass formed by ASM+
and not on the surface of the well (Figure 1). It is likely
that through the initial interaction of these putative
adhesins, individual PAO1 bacteria adhere to the mucin
glycoprotein forming the nuclei of the microcolonies
and leaving no bacteria to adhere to the plastic surface.
Individual nuclei would then recruit more PAO1 bac-
teria, possibly through additional inter-bacterial andglycoprotein-bacterial interactions, growing into well-
defined BLS observed over time (Figure 2).
Based on the work of Ghani & Soothill [15] and Srira-
mulu et al. [16], we utilized 0.5% mucin (1X) in our ASM+.
But more recently, Henke et al. [36], showed that the con-
centrations of MUC5AC and MUC5B, the principal gel-
forming mucins, are decreased in airway secretions from
CF patients with stable disease and greatly increased during
pulmonary exacerbations (by 89% and 908%, respectively).
When we reduced the mucin concentration of ASM+ by
50% (0.5X), the gelatinous mass still formed in the well,
possibly through the contribution of other ASM+ compo-
nents (DNA and lecithin) that add to the viscosity. How-
ever, the typical multilayered BLS was eliminated and
Figure 11 Elimination of AH133 BLS is due to the bactericidal effect of PAO1. PAO1/p7605 (red) gradually eliminates previously-formed
AH133 (green) BLS. ASM+was inoculated with AH133 and the cultures were grown for 8 h to allow for the partial development of AH133 BLS.
(A) One culture was continued without addition of PAO1 for a total of 64 h. (B) The other culture was inoculated with PAO1/p7605 (starting
density similar to that used to initiate the AH133 culture). Incubation was continued for an additional 56 h and cultures were analyzed at 8- to
16-h intervals by CLSM (exact time points indicated above and below micrographs). (C) PAO1 is bactericidal to AH133. Two sets of wells
containing ASM+were inoculated with AH133 and incubated for 8 h. PAO1/pMP7605 was added to one set of wells and incubation of both sets
was continued for 56 h. At the specified time points, the gelatinous mass was obtained and the CFU/ml of each species was determined using
selective media (Methods). White bars: AH133 CFU/ml in single culture; green bars, CFU/ml of AH133 in the co-culture; red bars, CFU/ml of
PAO1/pMP7605 from the co-culture. Values represent the means of at least three independent experiments ± SEM.
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microcolonies amid individual cells and tiny cell clusters
distributed throughout most of the gelatinous mass
(Figure 4A, B). Surprisingly, the effect of increasing the
concentration of mucin to 2X on the development of BLS
was similar to that induced by reducing the mucin concen-
tration. Rather than the distinct highly structured BLS
architecture, PAO1 produced small microcolonies distribu-
ted throughout the ASM+ (Figure 4C). At this time, we do
not know if the increase in the availability of mucin glyco-
protein interferes with the development of microcolonies
that coalesce to form the well-developed BLS.
One of the hallmarks of the CF syndrome is the over-
production of mucin within the lung alveoli [1,3,7]. Yet
during P. aeruginosa infection of the CF lung alveoli, the
level of mucin may vary [36]. P. aeruginosa LPS induces
the production of reactive oxygen intermediates, whichcause release of transforming growth factor α; TGF-α then
up-regulates the expression of MUC-5 AC thereby caus-
ing excessive mucin production[37-39]. However, P. aeru-
ginosa produces other factors that may reduce the amount
of mucus within its immediate vicinity; alveolar mucin is
degraded by P. aeruginosa extracellular serine proteases
such as LasB [40]. Ultimately, the interaction of all these
factors would produce a net mucin concentration suitable
for the full development of the BLS, while any imbalance
in the production of these factors that reduces or increases
mucin concentration would prevent the establishment of
the BLS. Alternatively, BLS may form in the initial stages
of P. aeruginosa infection in the CF lung. Treatment that
reduces the amount of mucin present would disperse the
bacteria making them more susceptible to antibacterial
treatment (stable disease). Alternatively, mucin may re-
duce the chances of forming new BLS.
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cosity of CF sputum [15,16]. Within the CF lung, there
are several sources for this extracellular DNA – dead
host immune cells, lysed bacteria, QS-regulated release
of P. aeruginosa DNA, and outer membrane vesicles that
contain DNA [41,42]. Like mucin, DNA contributes to
biofilm formation as well; a similar biofilm was detected
on a glass surface coated with DNA [41]. Previous stud-
ies using other biofilm development media, such as LB
or minimal medium, indicated that extracellular DNA is
critical for the initial establishment of P. aeruginosa bio-
films [42]. The levels of extracellular DNA also vary
within CF sputum, ranging from 0.3 to 9.5 mg/ml in one
study of 167 CF sputum samples [43]. Variations in the
level of extracellular DNA in ASM+ affected the develop-
ment of BLS much more dramatically than variations in
the level of mucin. In ASM+ with 0.5X DNA (2 mg/ml), a
well developed BLS was visible (Figure 5B), but the biovo-
lume and total surface area occupied were considerably
less (Table 1 and 2). When the amount of DNA was
increased to 1.5X (6 mg/ml), PAO1 did not produce de-
tectable structures; rather, the gelatinous mass formed by
the ASM+ contained scattered individual cells (Figure 4C).
However, at this time it is not clear how an increase in the
external DNA reduces the number of BLS within the gelat-
inous mass of ASM+.
Within the lung of CF patients and during other
chronic lung infections, P. aeruginosa survives under
microaerobic (10% EO2) to anaerobic (0% EO2) condi-
tions. A steep oxygen gradient exists within the P. aeru-
ginosa infected alveolar mucus [5,21]. Within the
mucus, P. aeruginosa secretes compounds that lower the
oxygen transfer rate generating optimum conditions for
microaerobic growth [22,44]. We showed previously that
lower oxygen tension also influences the expression of
P. aeruginosa virulence genes [45]. Compared with aer-
obic conditions, the expression of pyoverdine genes was
reduced under microaerobic conditions; in contrast, the
expression of the exotoxin A gene, toxA was increased
[45]. Compared with 20% EO2 and 0% EO2, microaero-
bic (10% EO2) conditions are optimal for the develop-
ment of P. aeruginosa BLS in ASM+. BLS developed
under 10% EO2 had a greater mean thickness and a lar-
ger biovolume than those developed under either 20% or
0% EO2 (Figure 6, Table 1 and 2). In the absence of EO2,
PAO1 required 6 days to develop rudimentary BLS
(Figure 6C) indicating that a low level of oxygen is es-
sential for the full development of these structures.
Depending on conditions under which the biofilms
were developed (medium, the biofilm development sys-
tem, and the biofilm substrate), previous studies indi-
cated the involvement of the QS systems in the
development of P. aeruginosa biofilm [29,30,35,46]. In
those studies, the deficiency in biofilm development wasassociated with either a lasI or rhlI mutation. We tested
mutants defective in all three known P. aeruginosa QS
systems in ASM+. PAO-R1 (ΔlasR), PAO-JP1 (ΔlasI),
and PW2798::pqsA-lacZ (ΔpqsA) produced BLS that
were visually and architecturally similar to each
(Figure 8). In contrast, PDO111 (ΔrhlR) BLS were visu-
ally, architecturally, and structurally dissimilar to PAO1
BLS, in that they had a smaller biovolume and mean
thickness (Figure 8, Tables 3 and 4). The loss of rhlI
(PDO100) had the most profound effect on the BLS pro-
duced by PAO1 in ASM+. Both PDO100 (ΔrhlI) and
PDO111 (ΔrhlR) produced BLS that were significantly
smaller (biovolume, mean thickness) than PAO1 BLS
(Figure 8, Tables 3 and 4). However, BLS produced by
these two strains were more heterogeneous than PAO1
BLS (a significant increase in roughness coefficient)
(Figure 8, Tables 3 and 4). Additionally, more regions
of the PDO100 and PDO111 BLS were exposed to
nutrients than PAO1 BLS (a significantly higher sur-
face to biovolume values) (Figure 8, Tables 3 and 4).
Our results suggest that the production and maturation
of the fully-developed complex BLS requires a potential
P. aeruginosa factor that is stringently controlled by
the rhl and not the las or the pqs systems. Among the
P. aeruginosa factors that are stringently controlled by the
rhl system are the rhamnolipid biosurfactants [47,48]. The
rhamnolipids encoded by the rhlAB operon contribute to
biofilm development in P. aeruginosa through multiple
mechanisms including maintaining open channels by
affecting cell-to-cell interaction [28], promoting microcol-
ony formation in the initial stages of biofilm development
[49], and dispersing cells from the mature biofilms [50].
Analysis of PAOΔrhlA and/or PAOΔrhlB mutants in
ASM+ should allow us to determine if rhamnolipid plays
a role in the development of the BLS. Interestingly,
PA103, which is known to have a deletion in lasR [51],
produced BLS with reduced biovolume and mean
thickness (compared with those produced by PAO1 or
PAO-R1) (Figure 7, Tables 3 and 4). This suggests that the
observed differences between the BLS produced by PAO1
and PA103 are not due to the loss of the lasR gene in
PA103. CI-4, a clinical isolate obtained from a patient who
had been continuously infected with P. aeruginosa for
30 days, has deletions in both lasR and rhlR [27]. This
strain produced BLS that had less biovolume, mean thick-
ness and covered less total surface area that PAO1; visu-
ally, the BLS were also unique in appearance among all
the QS mutants, numerous small microcolonies distribu-
ted throughout the medium (Figure 7, Tables 3 and 4).
This suggests that there is a complex interaction among
the QS systems in controlling BLS production within
ASM+.
Using ASM+, which has the same components as our
ASM+, Sriramula et al. [16] examined the growth of PAO1,
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formed macroscopically visible clumps or aggregates, which
they termed tight microcolonies, that could not be dis-
turbed even with vigorous pipetting [16]. In contrast, PAO-
ΔlasR failed to develop these tight microcolonies [16]. In
our study, neither PAO1, nor any other tested strain pro-
duced macroscopically visible structures. In part, this is due
to the turbidity of ASM+. Similar to the tight microcolonies
described by Sriramula et al. [16], the BLS we observed in
our ASM+ did not attach to a surface. The BLS are adher-
ent when fully-developed, but cells within the BLS can be
dispersed by vortexing. Differences between the two stud-
ies, despite the similarity in the growth medium, are most
likely due to differences in other growth conditions. While
Sriramula et al. [16], grew their cultures under 20% EO2
with shaking, we grew our cultures under static conditions
regardless of the EO2 concentration. Given these differ-
ences, it is not practical to directly compare the bacterial
structures observed in the two studies with respect to the
role of the QS systems in their formation.
Biofilms at different infection sites often consist of
multiple species of bacterial pathogens [52,53]. These
bacterial species may either compete with each other or
support each other’s growth. Qin et al. [54] previously
showed that P. aeruginosa inhibited the planktonic
growth of Staphylococcus epidermidis through a QS-
related mechanism. Additionally, using the static cham-
ber cultivation system (microtiter plate assay), they
demonstrated that P. aeruginosa extracellular polysac-
charide disrupted an already established S. epidermidis
biofilm [54]. Disruption of these biofilms, however, does
not occur through the bactericidal effect observed with
the planktonic cells; instead the bacteria within the
biofilm were dispersed alive [54]. When we co-cultured
P. aeruginosa and S. aureus statically under 20% EO2 in
TSBDC or ASM+, P. aeruginosa eliminated S. aureus by
day 2 (Figure 10). Furthermore, and similar to the findings
by Qin et al. with S. epidermidis [54], the addition of
P. aeruginosa to S. aureus BLS established in ASM+ dis-
rupted the S. aureus BLS (11a, b). However, P. aeruginosa
disrupted the S. aureus BLS through an bactericidal effect
rather than dispersion. By 56-h post addition of PAO1, no
CFU of AH133 were recovered (Figure 11C), although it
is remotely possible that our failure to detect S. aureus is
due to their existence in a viable but nonculturable state.
This effect is similar to the clinical observations of CF
lung infections where S. aureus, an early colonizer, is grad-
ually replaced by P. aeruginosa. The nature of the PAO1
bactericidal factor that eliminates the S. aureus BLS is
under investigation.
Conclusions
In this study, we have demonstrated that thick, viscous
ASM+ containing mucin and extracellular DNA andincubated under static conditions with lowered oxygen
tension (10% EO2) – constituents and conditions similar
to those within the lung alveoli of CF patients – induces
the formation of biofilm-like structures by P. aerugi-
nosa and S. aureus, two of the pathogens most com-
monly seen in the infected lungs of these patients.
The BLS are not attached to the surface, but form
within the medium as has been reported for the de-
velopment of macrocolonies within the mucus in CF
lungs. Thus, ASM+ represents an in vitro medium in
which the effect of changing levels of substances pro-
duced by the host and the bacteria can be analyzed to
determine the effect on such structures and on the
susceptibility of the bacteria within the BLS to various
treatments.
Methods
Bacterial strains, plasmids, and media
Bacterial strains and plasmids utilized in this study are
described in Table 6. Strains were routinely grown
in Luria Bertani (LB) broth under shaking conditions at
37°C. To analyze the development of biofilm-like struc-
tures, bacterial strains were grown in the previously
described ASM+ [16]. To attain consistency from batch
to batch of medium ASM+ was made in a quantity suffi-
cient for each planned set of experiments, a stringent
method of preparing the medium was used. The compo-
nents were added into sterile water in exact order with
vigorous vortexing for 10–30 seconds after each
addition: mucin (Sigma-Aldrich, St. Louis, MO), 0.5%
(w/v); unsheared salmon sperm DNA (Sigma-Aldrich),
0.4% (w/v); NaCl, 0.5% (w/v); KCl, 0.2% (w/v); casamino
acids (Amresco, Solon, OH), 0.5% (w/v); egg yolk emul-
sion (source of lecithin; sterile; Remel, Lenexa, KS),
0.25% (v/v); diethylene triamine pentaacetic acid (1 mg/
ml stock in 1 M NaOH; sterile; Sigma), 0.0005% (w/v).
Finally, the pH was adjusted to 6.8. Antibiotics were
then added to maintain sterility and for maintenance of
plasmids: 300 μg carbenicillin/ml and/or 50 μg tetracyc-
line/ml for P. aeruginosa; 10 μg erythromycin/ml for
S. aureus. The completed medium was then vortexed for
2 minutes and again prior to pipetting. To induce bio-
film formation on the substrate surface, we used trypti-
case soy broth dialysate (TSBDC) to which glycerol
(1% v/v) and monosodium glutamate (0.5 M) were
added [55].
To allow visualization of the bacteria, all P. aeruginosa
strains were transformed by electroporation [63] with
pMRP9-1 from which the gene for green fluorescent
protein (GFP) is constitutively expressed [56]. To
visualize PAO1 grown together with AH133, PAO1 was
transformed with pMP7605 in which the mCherry gene
that codes for red fluorescent protein (RFP) is expressed
from the tac promoter [34]. The S. aureus strain AH133
Table 6 Strains and plasmids used in this study
Strain Description Source
Plasmids
pCM11 Plasmid stable in S. aureus that constitutively
expresses green fluorescent protein (GFP); Emr
Alexander Horswill, personal
communication
pMRP9-1 pUCP-18 cloning vector carrying a GFP cassette; Cbr [56]
pMP7605 pBBR1MCS-5 cloning vector carrying the mCherry
gene under the control of the tac promoter; Cbr
[34]
Pseudomonas aeruginosa
PA103 Human isolate [24]
PAK Prototroph; human isolate [57]
PAO1 Prototroph; human isolate [58]
PAO-R1 ΔlasR derivative of PAO1; Tcr [51]
PAO-JP1 ΔlasI derivative of PAO1; Tcr [59]
PDO111 rhlR::Tn501 derivative of PAO1; Hgr [60]
PDO100 ΔrhlI::Tn501 derivative of PAO1; Hgr [60]
PW2798::pqsA-lacZ pqsA-H05::ISlacZ/hah derivative of PAO1; Tcr [61]; University of Washington
Genome Center




AH133 RN4220 carrying pCM11; Emr [62]; Alexander Horswill, personal
communication
Em, erythromycin; r, resistant; Cb, carbenicillin; Hg, mercury; Tc, tetracycline.
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will, personal communication).
Static microtiter plate culture system for development of
the BLS
Bacteria were grown in a static microtiter plate culture
system using sterile 24-well polystyrene plates (Falcon;
BD, Franklin Lakes, NJ) [64,65]. Tested strains were
grown overnight in LB broth. Cells were pelleted,
washed, and resuspended in PBS. For analysis of the
BLS formed by individual bacterial species, resus-
pended cells were inoculated in ASM+ to an initial
OD600 of 0.02-0.03 and dispensed into the plate wells
in 1 ml aliquots. For the analysis of BLS produced by
two bacterial species, individual species were prepared
and inoculated at an initial OD600 of 0.015. The plates
were incubated at 37°C in static (nonshaking) condi-
tions under environmental oxygen (EO2) concentration
of 20% (aerobic), 10% (microaerobic), or 0% (anaer-
obic). Individual GasPak jars with Campy Pak Plus
envelopes (BD) or GasPak EZ Anaerobic Pouches (BD)
were used to generate the microaerobic and anaerobic
EO2 conditions, respectively.
Visualization of the BLS
This was done using confocal laser scanning microscopy
(CLSM) [35,64]. The BLS were visualized within thewells of the microtiter plates using an Olympus IX71
Fluoview 300 confocal laser scanning microscope (Olym-
pus America, Melville, NY). All images were obtained
through a 203/0.40 Ph1 NA objective utilizing a green
helium laser (546 nm) or argon laser (510–530 nm).
Three-dimensional image reconstructions were per-
formed using NIS-Elements 2.2 (Nikon Instruments,
Melville, NY) to visualize the architecture of the BLS.
All instrument settings were consistent for each individ-
ual experimental parameter tested.
Quantitative structural analysis of the BLS
The number of image stacks obtained from the BLS was
based on the greatest depth of the structures formed
under the test conditions and was the same for all
strains/conditions within an experiment (See Tables 1, 2,
3, 4). Each experiment was done in duplicate. Two 10-
image stacks were obtained from random positions within
each BLS (total 40-image stacks for each strain and/or
condition). The 40-image stacks were analyzed using the
COMSTAT program [20] for structural features of the
BLS: biovolume, estimates the biomass of the BLS; mean
thickness, a measure of spatial size of the BLS; roughness
coefficient, a measure of how much the thickness of the
BLS varies, or the heterogeneity of the BLS; total surface
area, space occupied in each image stack; and surface to
biovolume ratio, estimates the portion of the BLS exposed
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substratum). Values represent the mean± SEM.
Quantification of the bacteria within the BLS
The highly viscous ASM+ forms a gelatinous mass in
which the bacteria grow. Therefore, at the indicated time
points, the mass from each well was transferred to a
1.5 ml microcentrifuge tube and vigorously vortexed to
suspend the bacteria. The bacterial suspension was then
serially diluted tenfold in PBS and 10 μl aliquots of each
dilution were spotted on LB agar. For dual species
experiments, the aliquots were spotted on Pseudomonas
isolation agar (BD) to select for P. aeruginosa and man-
nitol salt agar (BD) to select for S. aureus. The plates
were incubated at 37°C for 16 h and the colonies of
microorganisms (CFU) were counted. The CFU/ml was
determined using the following formula: CFU counted x
dilution factor x 100.
Statistical analyses
Statistical analyses of the results were done using Graph-
Pad InStat 3.06 (GraphPad Software, San Diego, CA).
One-way ANOVA with the Tukey-Kramer multiple
comparisons post-test was used to determine significant
differences over time and among treatments. The t-test
was used to compare two strains or two treatments.
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